Charles Schwab’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.2M | Sell |
|
|||||
|
2025
Q1 | $8.16M | Sell |
|
|||||
|
2024
Q4 | $9.66M | Buy |
|
|||||
|
2024
Q3 | $9.66M | Buy |
|
|||||
|
2024
Q2 | $3.08M | Buy |
|
|||||
|
2024
Q1 | $2.85M | Buy |
|
|||||
|
2023
Q4 | $987K | Buy |
|
|||||
|
2023
Q3 | $673K | Hold |
|
|||||
|
2023
Q2 | $1.11M | Buy |
|
|||||
|
2023
Q1 | $1.09M | Buy |
|
|||||
|
2022
Q4 | $575K | Buy |
|
|||||
|
2022
Q3 | $834K | Buy |
|
|||||
|
2022
Q2 | $806K | Sell |
|
|||||
|
2022
Q1 | $996K | Buy |
|
|||||
|
2021
Q4 | $1.35M | Sell |
|
|||||
|
2021
Q3 | $2.51M | Buy |
|
|||||
|
2021
Q2 | $3.54M | Buy |
|
|||||
|
2021
Q1 | $3.98M | Buy |
|
|||||
|
2020
Q4 | $3.49M | Buy |
|
|||||
|
2020
Q3 | $1.12M | Buy |
|
|||||
|
2020
Q2 | $1.1M | Buy |
|
|||||
|
2020
Q1 | $548K | Sell |
|
|||||
|
2019
Q4 | $454K | Buy |
|
|||||
|
2019
Q3 | $332K | Buy |
|
|||||
|
2019
Q2 | $443K | Buy |
|
|||||
|
2019
Q1 | $291K | Buy |
|
|||||
|
2018
Q4 | $289K | Hold |
|
|||||
|
2018
Q3 | $500K | Hold |
|
|||||
|
2018
Q2 | $490K | Buy |
|
|||||
|
2018
Q1 | $349K | Buy |
|
|||||
|
2017
Q4 | $172K | Hold |
|
|||||
|
2017
Q3 | $238K | Hold |
|
|||||
|
2017
Q2 | $357K | Hold |
|
|||||
|
2017
Q1 | $358K | Hold |
|
|||||
|
2016
Q4 | $322K | Buy |
|
|||||
|
2016
Q3 | $128K | Hold |
|
|||||
|
2016
Q2 | $92K | Hold |
|
|||||
|
2016
Q1 | $180K | Hold |
|
|||||
|
2015
Q4 | $175K | Hold |
|
|||||
|
2015
Q3 | $262K | Hold |
|
|||||
|
2015
Q2 | $391K | Buy |
|
|||||
|
2015
Q1 | $349K | Buy |
|